# Sally Beauty Holdings, Inc.: financial statements, quarterly

SBH · NYSE · CIK 1368458 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/sbh.md) · [Financials](/companies/sbh/financials.md) · [Filings](/companies/sbh/filings.md) · [Insiders](/companies/sbh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sbh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [921 d](/filings/0001193125-25-280122.md) | [931](/filings/0000950170-25-019869.md) | [908](/filings/0000950170-25-069145.md) | [942](/filings/0000950170-25-103040.md) | [935 d](/filings/0001193125-25-280122.md) | [938](/filings/0001193125-26-042785.md) | [883](/filings/0001193125-26-216750.md) | [933](/filings/0001368458-26-000007.md) | [947 d](/filings/0001193125-25-280122.md) | [943](/filings/0001193125-26-042785.md) | [903](/filings/0001193125-26-216750.md) | [935](/filings/0001368458-26-000007.md) |
| Cost of revenue | $m | [455 d](/filings/0001193125-25-280122.md) | [464](/filings/0000950170-25-019869.md) | [445](/filings/0000950170-25-069145.md) | [461](/filings/0000950170-25-103040.md) | [456 d](/filings/0001193125-25-280122.md) | [461](/filings/0001193125-26-042785.md) | [424](/filings/0001193125-26-216750.md) | [452](/filings/0001368458-26-000007.md) | [453 d](/filings/0001193125-25-280122.md) | [460](/filings/0001193125-26-042785.md) | [428](/filings/0001193125-26-216750.md) | [445](/filings/0001368458-26-000007.md) |
| Gross profit | $m | [467 d](/filings/0001193125-25-280122.md) | [467](/filings/0000950170-25-019869.md) | [463](/filings/0000950170-25-069145.md) | [481](/filings/0000950170-25-103040.md) | [479 d](/filings/0001193125-25-280122.md) | [477](/filings/0001193125-26-042785.md) | [459](/filings/0001193125-26-216750.md) | [481](/filings/0001368458-26-000007.md) | [494 d](/filings/0001193125-25-280122.md) | [483](/filings/0001193125-26-042785.md) | [476](/filings/0001193125-26-216750.md) | [490](/filings/0001368458-26-000007.md) |
| Selling, general and administrative | $m | [391 d](/filings/0001193125-25-280122.md) | [398](/filings/0000950170-25-019869.md) | [403](/filings/0000950170-25-069145.md) | [409](/filings/0000950170-25-103040.md) | [397 d](/filings/0001193125-25-280122.md) | [377](/filings/0001193125-26-042785.md) | [389](/filings/0001193125-26-216750.md) | [403](/filings/0001368458-26-000007.md) | [414 d](/filings/0001193125-25-280122.md) | [407](/filings/0001193125-26-042785.md) | [404](/filings/0001193125-26-216750.md) | [404](/filings/0001368458-26-000007.md) |
| Operating income | $m | [76.9 d](/filings/0001193125-25-280122.md) | [69.1](/filings/0000950170-25-019869.md) | [59.6](/filings/0000950170-25-069145.md) | [71.8](/filings/0000950170-25-103040.md) | [82.3 d](/filings/0001193125-25-280122.md) | [100](/filings/0001193125-26-042785.md) | [69.4](/filings/0001193125-26-216750.md) | [78.2](/filings/0001368458-26-000007.md) | [79.9 d](/filings/0001193125-25-280122.md) | [75.9](/filings/0001193125-26-042785.md) | [71.9](/filings/0001193125-26-216750.md) | [86.4](/filings/0001368458-26-000007.md) |
| Interest expense | $m | [19.7 d](/filings/0001193125-25-280122.md) | [17.3](/filings/0000950170-25-019869.md) | [20.5](/filings/0000950170-25-069145.md) | [20.7](/filings/0000950170-25-103040.md) | [17.9 d](/filings/0001193125-25-280122.md) | [17.4](/filings/0001193125-26-042785.md) | [16.3](/filings/0001193125-26-216750.md) | [15.7](/filings/0000950170-25-103040.md) | [15.0 d](/filings/0001193125-25-280122.md) | [14.6](/filings/0001193125-26-042785.md) | [14.2](/filings/0001193125-26-216750.md) | not reported |
| Income tax | $m | [14.6 d](/filings/0001193125-25-280122.md) | [13.4](/filings/0000950170-25-019869.md) | [9.8](/filings/0000950170-25-069145.md) | [13.3](/filings/0000950170-25-103040.md) | [16.3 d](/filings/0001193125-25-280122.md) | [21.9](/filings/0001193125-26-042785.md) | [13.9](/filings/0001193125-26-216750.md) | [16.7](/filings/0001368458-26-000007.md) | [15.1 d](/filings/0001193125-25-280122.md) | [15.8](/filings/0001193125-26-042785.md) | [15.1](/filings/0001193125-26-216750.md) | [18.6](/filings/0001368458-26-000007.md) |
| Net income | $m | [42.6 d](/filings/0001193125-25-280122.md) | [38.4](/filings/0000950170-25-103040.md) | [29.2](/filings/0000950170-25-103040.md) | [37.7](/filings/0000950170-25-103040.md) | [48.1 d](/filings/0001193125-25-280122.md) | [61.0](/filings/0001368458-26-000007.md) | [39.2](/filings/0001368458-26-000007.md) | [45.7](/filings/0001368458-26-000007.md) | [49.9 d](/filings/0001193125-25-280122.md) | [45.6](/filings/0001368458-26-000007.md) | [42.7](/filings/0001368458-26-000007.md) | [54.1](/filings/0001368458-26-000007.md) |
| Diluted EPS | $ per share | not reported | [0.35](/filings/0000950170-25-019869.md) | [0.27](/filings/0000950170-25-069145.md) | [0.36](/filings/0000950170-25-103040.md) | not reported | [0.58](/filings/0001193125-26-042785.md) | [0.38](/filings/0001193125-26-216750.md) | [0.44](/filings/0001368458-26-000007.md) | not reported | [0.45](/filings/0001193125-26-042785.md) | [0.43](/filings/0001193125-26-216750.md) | [0.55](/filings/0001368458-26-000007.md) |
| Basic EPS | $ per share | not reported | [0.36](/filings/0000950170-25-019869.md) | [0.28](/filings/0000950170-25-069145.md) | [0.37](/filings/0000950170-25-103040.md) | not reported | [0.60](/filings/0001193125-26-042785.md) | [0.39](/filings/0001193125-26-216750.md) | [0.46](/filings/0001368458-26-000007.md) | not reported | [0.47](/filings/0001193125-26-042785.md) | [0.44](/filings/0001193125-26-216750.md) | [0.57](/filings/0001368458-26-000007.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [123](/filings/0000950170-24-127217.md) | [121](/filings/0000950170-24-009857.md) | [97.2](/filings/0000950170-24-057042.md) | [97.4](/filings/0000950170-24-094050.md) | [108](/filings/0001193125-25-280122.md) | [106](/filings/0000950170-25-019869.md) | [92.2](/filings/0000950170-25-069145.md) | [113](/filings/0000950170-25-103040.md) | [149](/filings/0001368458-26-000007.md) | [157](/filings/0001193125-26-042785.md) | [157](/filings/0001193125-26-216750.md) | [173](/filings/0001368458-26-000007.md) |
| Current assets | $m | [1,228](/filings/0000950170-24-127217.md) | [1,263](/filings/0000950170-24-009857.md) | [1,280](/filings/0000950170-24-057042.md) | [1,263](/filings/0000950170-24-094050.md) | [1,305](/filings/0001193125-25-280122.md) | [1,247](/filings/0000950170-25-019869.md) | [1,239](/filings/0000950170-25-069145.md) | [1,262](/filings/0000950170-25-103040.md) | [1,301](/filings/0001368458-26-000007.md) | [1,286](/filings/0001193125-26-042785.md) | [1,293](/filings/0001193125-26-216750.md) | [1,311](/filings/0001368458-26-000007.md) |
| Total assets | $m | [2,725](/filings/0001193125-25-280122.md) | [2,731](/filings/0000950170-24-009857.md) | [2,747](/filings/0000950170-24-057042.md) | [2,721](/filings/0000950170-24-094050.md) | [2,793](/filings/0001193125-25-280122.md) | [2,711](/filings/0000950170-25-019869.md) | [2,706](/filings/0000950170-25-069145.md) | [2,744](/filings/0000950170-25-103040.md) | [2,871](/filings/0001368458-26-000007.md) | [2,851](/filings/0001193125-26-042785.md) | [2,853](/filings/0001193125-26-216750.md) | [2,883](/filings/0001368458-26-000007.md) |
| Current liabilities | $m | [579](/filings/0000950170-24-127217.md) | [573](/filings/0000950170-24-009857.md) | [644](/filings/0000950170-24-057042.md) | [595](/filings/0000950170-24-094050.md) | [593](/filings/0001193125-25-280122.md) | [549](/filings/0000950170-25-019869.md) | [533](/filings/0000950170-25-069145.md) | [524](/filings/0000950170-25-103040.md) | [576](/filings/0001368458-26-000007.md) | [542](/filings/0001193125-26-042785.md) | [553](/filings/0001193125-26-216750.md) | [554](/filings/0001368458-26-000007.md) |
| Total liabilities | $m | [2,217](/filings/0000950170-24-127217.md) | [2,190](/filings/0000950170-24-009857.md) | [2,196](/filings/0000950170-24-057042.md) | [2,144](/filings/0000950170-24-094050.md) | [2,164](/filings/0001193125-25-280122.md) | [2,054](/filings/0000950170-25-019869.md) | [2,006](/filings/0000950170-25-069145.md) | [1,981](/filings/0000950170-25-103040.md) | [2,077](/filings/0001368458-26-000007.md) | [2,027](/filings/0001193125-26-042785.md) | [2,015](/filings/0001193125-26-216750.md) | [2,012](/filings/0001368458-26-000007.md) |
| Long-term debt | $m | [1,078](/filings/0000950170-24-127217.md) | [1,077](/filings/0000950170-24-009857.md) | [996](/filings/0000950170-24-057042.md) | [995](/filings/0000950170-24-094050.md) | [994](/filings/0001193125-25-280122.md) | [953](/filings/0000950170-25-019869.md) | [917](/filings/0000950170-25-069145.md) | [896](/filings/0000950170-25-103040.md) | [875](/filings/0001368458-26-000007.md) | [855](/filings/0001193125-26-042785.md) | [835](/filings/0001193125-26-216750.md) | [815](/filings/0001368458-26-000007.md) |
| Shareholders' equity | $m | [509](/filings/0001193125-25-280122.md) | [541](/filings/0000950170-25-103040.md) | [551](/filings/0000950170-25-103040.md) | [578](/filings/0000950170-25-103040.md) | [629](/filings/0001368458-26-000007.md) | [656](/filings/0001368458-26-000007.md) | [700](/filings/0001368458-26-000007.md) | [763](/filings/0001368458-26-000007.md) | [794](/filings/0001368458-26-000007.md) | [824](/filings/0001368458-26-000007.md) | [838](/filings/0001368458-26-000007.md) | [871](/filings/0001368458-26-000007.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [117 d](/filings/0001193125-25-280122.md) | [51.0](/filings/0000950170-25-019869.md) | [36.9 d](/filings/0000950170-25-069145.md) | [47.9 d](/filings/0000950170-25-103040.md) | [111 d](/filings/0001193125-25-280122.md) | [33.5](/filings/0001193125-26-042785.md) | [51.1 d](/filings/0001193125-26-216750.md) | [69.4 d](/filings/0001368458-26-000007.md) | [121 d](/filings/0001193125-25-280122.md) | [93.2](/filings/0001193125-26-042785.md) | [73.3 d](/filings/0001193125-26-216750.md) | [80.9 d](/filings/0001368458-26-000007.md) |
| Capital expenditure | $m | [26.9 d](/filings/0001193125-25-280122.md) | [30.6](/filings/0000950170-25-019869.md) | [14.1 d](/filings/0000950170-25-069145.md) | [19.1 d](/filings/0000950170-25-103040.md) | [37.4 d](/filings/0001193125-25-280122.md) | [20.1](/filings/0001193125-26-042785.md) | [18.9 d](/filings/0001193125-26-216750.md) | [20.3 d](/filings/0001368458-26-000007.md) | [42.9 d](/filings/0001193125-25-280122.md) | [35.8](/filings/0001193125-26-042785.md) | [29.2 d](/filings/0001193125-26-216750.md) | [19.3 d](/filings/0001368458-26-000007.md) |
| Share repurchases | $m | not reported | [20.2](/filings/0000950170-25-019869.md) | [20.2 d](/filings/0000950170-25-069145.md) | [10.1 d](/filings/0000950170-25-103040.md) | [9.9 d](/filings/0001193125-25-280122.md) | [9.9](/filings/0001193125-26-042785.md) | [10.2 d](/filings/0001193125-26-216750.md) | [13.2 d](/filings/0001368458-26-000007.md) | [20.7 d](/filings/0001193125-25-280122.md) | [20.8](/filings/0001193125-26-042785.md) | [25.6 d](/filings/0001193125-26-216750.md) | [25.6 d](/filings/0001368458-26-000007.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [109](/filings/0000950170-24-009857.md) | [110](/filings/0000950170-24-057042.md) | [110](/filings/0000950170-24-094050.md) | [109](/filings/0000950170-25-019869.md) | [107](/filings/0000950170-25-069145.md) | [106](/filings/0000950170-25-103040.md) | [105](/filings/0001193125-26-042785.md) | [104](/filings/0001193125-26-216750.md) | [103](/filings/0001368458-26-000007.md) | [101](/filings/0001193125-26-042785.md) | [99.7](/filings/0001193125-26-216750.md) | [97.9](/filings/0001368458-26-000007.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 93,622,292 at 2026-07-30, from the cover of the [10-Q filed 2026-08-03](/filings/0001368458-26-000007.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.